The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics
Open Access
- 20 December 2016
- journal article
- review article
- Published by Springer Nature in Cell & Bioscience
- Vol. 6 (1) , 1-15
Abstract
The addition of mono-ubiquitin or poly-ubiquitin chain to signaling proteins in response to DNA damage signal is thought to be a critical event that facilitates the recognition of DNA damage lesion site, the activation of checkpoint function, termination and checkpoint response and the recruitment of DNA repair proteins. Despite the ubiquitin modifiers, removal of ubiquitin from the functional proteins by the deubiquitinating enzymes (DUBs) plays an important role in orchestrating DNA damage response as well as DNA repair processes. Deregulated ubiquitination and deubiquitination could lead to genome instability that in turn causes tumorigenesis. Recent TCGA study has further revealed the connection between mutations in alteration of DUBs and various types of tumors. In addition, emerging drug design based on DUBs provides a new avenue for anti-cancer therapy. In this review, we will summarize the role of deubiquitination and specificity of DUBs, and highlight the recent discoveries of DUBs in the modulation of ubiquitin-mediated DNA damage response and DNA damage repair. We will furthermore discuss the DUBs involved in the tumorigenesis as well as interception of deubiquitination as a novel strategy for anti-cancer therapy.Keywords
Funding Information
- National Institutes of Health (R01CA154695, R01CA202948, R01CA202963)
This publication has 158 references indexed in Scilit:
- Playing the End Game: DNA Double-Strand Break Repair Pathway ChoiceMolecular Cell, 2012
- RNF8‐ and RNF168‐dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sitesThe EMBO Journal, 2012
- Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseasesExpert Reviews in Molecular Medicine, 2011
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer CellsChemistry & Biology, 2011
- Ube2w and Ataxin-3 Coordinately Regulate the Ubiquitin Ligase CHIPMolecular Cell, 2011
- A structural model for regulation of NHEJ by DNA-PKcs autophosphorylationDNA Repair, 2010
- The DNA Damage Response: Making It Safe to Play with KnivesMolecular Cell, 2010
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53Cell, 2010
- Distinct Modes of Regulation of the Uch37 Deubiquitinating Enzyme in the Proteasome and in the Ino80 Chromatin-Remodeling ComplexMolecular Cell, 2008
- Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune ResponsesCell Host & Microbe, 2007